$13.78
À la clôture: Nov 19, 4:00 PM EST

Mineralys Therapeutics (MLYS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $-0.64 | $-0.54 | -18.5 % |
| Q2 | Aug 11, 2026 | $-2.85 | $-0.54 | -427.8 % |
| Q1 | May 6, 2026 | $-0.47 | $-0.45 | -4.44 % |
| Q4 | Mar 12, 2026 | $-0.40 | $-0.54 | 25.9 % |
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.54 | $-0.54 | $-0.45 | $-0.54 |
| Actual | $-0.64 | $-2.85 | $-0.47 | $-0.40 |
| Surprise | -18.5% | -427.8% | -4.44% | +25.9% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | — | — | $0 |
| Surprise | — | — | — | — |
| Metric | Q4 '26E | Q1 '27E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.67 | $-0.81 |
| Revenue | ||
| Consensus | — | $1.4M |